当前位置:首页 - 行情中心 - 益方生物-U(688382) - 财务分析 - 现金流量表

益方生物-U

(688382)

  

流通市值:124.52亿  总市值:124.52亿
流通股本:5.78亿   总股本:5.78亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金-107,606,156.9218,233,258.8810,331,979.22
  收到其他与经营活动有关的现金4,522,773.3518,276,120.9317,343,177.0713,383,947.86
  经营活动现金流入小计4,522,773.35125,882,277.8535,576,435.9523,715,927.08
  购买商品、接受劳务支付的现金117,057,654.28152,842,385.8299,269,898.8862,225,112.36
  支付给职工以及为职工支付的现金28,759,310.62114,595,594.0188,822,416.7163,887,002.76
  支付的各项税费106,895.45434,186.19329,926.72213,682.55
  支付其他与经营活动有关的现金1,227,773.6913,454,936.817,210,577.574,640,029.77
  经营活动现金流出小计147,151,634.04281,327,102.83195,632,819.88130,965,827.44
  经营活动产生的现金流量净额平衡项目0000.01
  经营活动产生的现金流量净额-142,628,860.69-155,444,824.98-160,056,383.93-107,249,900.35
二、投资活动产生的现金流量:
  收回投资收到的现金562,891,158.841,264,547,162.41935,482,609.3210,000,000
  取得投资收益收到的现金4,888,366.2616,562,537.1814,913,198.362,084,099.81
  投资活动现金流入小计567,779,525.11,281,109,699.59950,395,807.66212,084,099.81
  购建固定资产、无形资产和其他长期资产支付的现金1,929,685.16,916,564.926,274,311.625,118,259.7
  投资支付的现金747,292,134.151,300,521,387.021,026,483,821.51500,318,140
  投资活动现金流出小计749,221,819.251,307,437,951.941,032,758,133.13505,436,399.7
  投资活动产生的现金流量净额-181,442,294.15-26,328,252.35-82,362,325.47-293,352,299.89
三、筹资活动产生的现金流量:
  吸收投资收到的现金-6,974,337.66,974,337.66,884,523.15
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-6,974,337.66,974,337.66,884,523.15
  支付其他与筹资活动有关的现金13,128,416.7813,194,666.385,843,945.243,695,841.8
  筹资活动现金流出小计13,128,416.7813,194,666.385,843,945.243,695,841.8
  筹资活动产生的现金流量净额-13,128,416.78-6,220,328.781,130,392.363,188,681.35
四、汇率变动对现金及现金等价物的影响-1,211,496.6-2,833,438.79-2,492,032.99-905,461.13
  现金及现金等价物净增加额平衡项目000-0.01
五、现金及现金等价物净增加额-338,411,068.22-190,826,844.9-243,780,350.03-398,318,980.03
  加:期初现金及现金等价物余额723,119,723.29913,946,568.19913,946,568.19913,946,568.19
  期末现金及现金等价物余额384,708,655.07723,119,723.29670,166,218.16515,627,588.16
补充资料:
  净利润--316,865,800.68--119,432,479.85
  固定资产和投资性房地产折旧-4,904,703.73-2,482,027.05
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-4,904,703.73-2,482,027.05
  无形资产摊销-697,234.08-240,081.36
  长期待摊费用摊销-1,637,645.13-545,881.71
  公允价值变动损失--2,488,403.42--886,746.71
  财务费用--12,392,148.95--3,980,199.96
  投资损失--901,325.59--84,099.81
  递延所得税-239,526-0
  其中:递延所得税资产减少-250,825.25--14,556.84
    递延所得税负债增加--11,299.25-14,556.84
  经营性应收项目的减少-58,685,249.68--10,018,176.45
  经营性应付项目的增加-53,781,234.36--16,706,667.49
  其他-35,730,434.47-20,330,884.47
  现金的期末余额-723,119,723.29-515,627,588.16
  减:现金的期初余额-913,946,568.19-913,946,568.19
  现金及现金等价物的净增加额--190,826,844.9--398,318,980.03
公告日期2026-04-292026-04-152025-10-302025-08-23
审计意见(境内)标准无保留意见
TOP↑